The company acquired additional shares of ACA Next Co., Ltd. on February 26, 2026, increasing its voting rights from 16.3% to 40.3%, thereby establishing substantive control and consolidating it as a subsidiary. The acquisition cost was approximately 914 million yen (900 million yen for shares plus 14 million yen in due diligence fees). The transaction was motivated by synergies between the company's consumer channels and ACA Next's B2B institutional sales network in healthcare and welfare facilities.
¥914M
›
Summary
The company acquired additional shares of ACA Next Co., Ltd. on February 26, 2026, increasing its voting rights from 16.3% to 40.3%, thereby establishing substantive control and consolidating it as a subsidiary. The acquisition cost was approximately 914 million yen (900 million yen for shares plus 14 million yen in due diligence fees). The transaction was motivated by synergies between the company's consumer channels and ACA Next's B2B institutional sales network in healthcare and welfare facilities.